HIGHLIGHTS
- who: TYPE et al. from the Cordeliers (CRC), France University Hospital, Heidelberg, Germany, Translational Lung Research Center at Heidelberg have published the paper: Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation, in the Journal: (JOURNAL)
- future: Recent developments in these fields offer a justified hope for cure of several cancers in the near future a snapshot of which the current Research Topic aspired to capture. burden (TMB) pose technical challenges and have failed to meet expectations .
SUMMARY
ACCEPTED immune checkpoint inhibitors, immune microenviroment, immune dysregulation, cell therapies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.